A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...
Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...
After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 ...
Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...
9News.com.au on MSN2d
Cost of lifesaving diabetes drug to be slashedA new treatment, which is set to transform the lives of type two diabetes patients, is now on the PBS - halving its price.
Verywell Health on MSN2d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...
Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback